Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-23-034479

Options or other derivatives

  • CEO acquired 3,338,878 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Spoor Johan M. CEO 2023-12-12 Grant or award · Stock Options (right to buy) +3,338,878 11,793,635 D: show line 1 in the form
Loading xslF345X05/rdgdoc.xml…